| VERTEX PHARMACEUTICALS |
| USA |
| Gesundheit |
| US92532F1003 / 882807 |
| VX1 (Frankfurt) / VRTX (NASDAQ) |
| FRA:VX1, ETR:VX1, VX1:GR, NASDAQ:VRTX |
| https://www.vrtx.com/ |
|
Vertex Pharmaceuticals Incorporated is a leading biotechnology company founded in 1989 and headquartered in Boston, Massachusetts. It specializes in the discovery, development, and commercialization o..
>Volltext.. |
| 100398.41 Mio. EUR |
| 96592.76 Mio. EUR |
| 9861.8 Mio. EUR |
| 3989.51 Mio. EUR |
| 3088.46 Mio. EUR |
| 12.04 EUR |
| 1541.92 Mio. EUR |
| 4158.01 Mio. EUR |
| 3124.51 Mio. EUR |
| 1.41 |
| 4.87% |
| - |
| - |
| - |
| - |
| VERTEX PHARMACEUTICALS, VERTEX PHARMA, VRTX |
| 13.02.26 |
|
||||
|